IMMULITE 2000 Systems IPT Intact PTHRecalls & reported problems across all models
Siemens Healthcare Diagnostics Products Ltd · 2 models in the FDA device registry
Data updated Oct 16, 2026 from official FDA records · Editorial policy
1 open recall names at least one IMMULITE 2000 Systems IPT Intact PTH model. Check whether yours is affected in the recall details, and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 18
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls
- 1
We found 2 models of IMMULITE 2000 Systems IPT Intact PTH by Siemens Healthcare Diagnostics Products Ltd in the FDA's device registry (GUDID). Together they are named in 18 adverse event reports in the FDA's MAUDE database, received between Jun 29, 2017 and Jan 13, 2026 — classified as 18 malfunctions.
The most frequently reported specific device problem is “Low Test Results” (9 reports).
1 FDA recall record name at least one of these models by its device identifier, 1 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works
Reports received per month, all models
IMMULITE 2000 Systems IPT Intact PTH recalls
FDA recall records that name at least one of these models by its device identifier, newest first. Each recall usually covers specific models or lots, so check the details.
- Sep 22, 2025Open, Classified
The potential for falsely depressed Intact PTH patient results at the low end of the assay range, less than or equal to 50 pg/mL (less than or equal to 5.3 pmol/L), when using specific lots identified by the firm on the IMMULITE 2000/IMMULITE 2000 XPi systems. The bias is observed in both serum and plasma samples.
Z-0366-2026 · Root cause: Under Investigation by firm · names 2 of these models · Recall details · FDA record ↗
Most reported IMMULITE 2000 Systems IPT Intact PTH problems
Device problems
- Adverse Event Without Identified Device or Use Problem9
- Low Test Results9
Patient problems
- No Known Impact Or Consequence To Patient17
- No Clinical Signs, Symptoms or Conditions1
IMMULITE 2000 Systems IPT Intact PTH models
2 models, most reported first. Each model has its own page with its reports, recalls and device details.
- IMMULITE® 2000 Systems IPT Intact PTH 10381441RADIOIMMUNOASSAY, PARATHYROID HORMONE1 recall18 reports
- IMMULITE® 2000 Systems IPT Intact PTH 10381442RADIOIMMUNOASSAY, PARATHYROID HORMONE1 recall0 reports
Recent IMMULITE 2000 Systems IPT Intact PTH adverse event reports
The 15 most recent reports across all models, in the reporter's own words as published by the FDA.
MalfunctionJan 13, 2026Low Test Results
THE CUSTOMER REPORTED THE OBSERVATION OF AN 'INCREASED INCIDENCE OF LOW VALUES' WHEN USING INTACT PTH LOT 387 ON AN IMMULITE 2000 XPI INSTRUMENT. THE CUSTOMER PROVIDED THE RESULTS OF EIGHT PATIENTS COMPARED TO AN ALTERNATE, NON-SIEMENS, METHOD. THE IMMULITE 2000 XPI RESULTS WERE NOT REPORTED TO THE PHYSICIAN(S). QUALITY CONTROL (QC) WAS WITHIN ACCEPTABLE RANGES AT THE TIME OF TESTING. CLINICAL CONTEXT IS UNKNOWN AND THE REFERENCE RANGE FOR THE ALTERNATE METHOD IS UNKNOWN AS WELL. THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THIS ISSUE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24055532 ↗MalfunctionNov 15, 2018Low Test Results; Low Test Results
A DISCORDANT FALSELY LOW RESULT (BELOW REFERENCE RANGE OF THE ASSAY ) WAS OBTAINED ON A PATIENT SAMPLE FOR INTACT PARATHYROID (IPTH) ASSAY ON AN IMMULITE 2000 (INSTRUMENT 1) INSTRUMENT WHEN USING IPTH KIT LOT 332. THE INITIAL RESULT OBTAINED ON INSTRUMENT 1 WAS REPORTED TO THE PHYSICIAN(S) AND QUESTIONED. THE SAMPLE WAS THEN REPEATED ON ANOTHER IMMULITE 2000 INSTRUMENT (INSTRUMENT 2) IN THE SAME LABORATORY TWICE USING IPTH KIT LOT 333 AND THE RESULT WAS STILL LOW (BELOW REFERENCE RANGE OF THE ASSAY). THE RESULT OBTAINED ON INSTRUMENT 2 WAS NOT REPORTED TO THE PHYSICIAN(S). THE SAMPLE WAS THEN TESTED ON AN ALTERNATE NON-SIEMENS PLATFORM AND THE RESULT WAS WITHIN THE REFERENCE RANGE OF THAT ASSAY. THE CUSTOMER IS UNCLEAR WHAT THE TRUE EXPECTED RESULT IS BUT HAS INDICATED THAT THE PHYSICIAN(S) EXPECTED A RESULT HIGHER THAN THE RESULT ON INSTRUMENT 1. THERE WERE NO PREVIOUS IPTH RESULTS ON THIS PATIENT SAMPLE. THE CUSTOMER HAS INDICATED THAT QUALITY CONTROL SAMPLES RECOVERED WITHIN SPECIFICATIONS ON THE DAY THE DISCORDANT RESULT(S) WERE OBTAINED ON BOTH THE IMMULITE 2000 INSTRUMENTS, AND THAT THE SAMPLE WAS FROZEN IN BETWEEN TESTING ON THE INSTRUMENT(S). THERE ARE NO REPORTS OF PATIENT
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 8074744 ↗MalfunctionNov 15, 2018Low Test Results; Low Test Results
A DISCORDANT FALSELY LOW RESULT (BELOW REFERENCE RANGE OF THE ASSAY ) WAS OBTAINED ON A PATIENT SAMPLE FOR INTACT PARATHYROID (IPTH) ASSAY ON AN IMMULITE 2000 (INSTRUMENT 1) INSTRUMENT WHEN USING IPTH KIT LOT 332. THE INITIAL RESULT OBTAINED ON INSTRUMENT 1 WAS REPORTED TO THE PHYSICIAN(S) AND QUESTIONED. THE SAMPLE WAS THEN REPEATED ON ANOTHER IMMULITE 2000 INSTRUMENT (INSTRUMENT 2) IN THE SAME LABORATORY TWICE USING IPTH KIT LOT 333 AND THE RESULT WAS STILL LOW (BELOW REFERENCE RANGE OF THE ASSAY). THE RESULT OBTAINED ON INSTRUMENT 2 WAS NOT REPORTED TO THE PHYSICIAN(S). THE SAMPLE WAS THEN TESTED ON AN ALTERNATE NON-SIEMENS PLATFORM AND THE RESULT WAS WITHIN THE REFERENCE RANGE OF THAT ASSAY. THE CUSTOMER IS UNCLEAR WHAT THE TRUE EXPECTED RESULT IS BUT HAS INDICATED THAT THE PHYSICIAN(S) EXPECTED A RESULT HIGHER THAN THE RESULT ON INSTRUMENT 1. THERE WERE NO PREVIOUS IPTH RESULTS ON THIS PATIENT SAMPLE. THE CUSTOMER HAS INDICATED THAT QUALITY CONTROL SAMPLES RECOVERED WITHIN SPECIFICATIONS ON THE DAY THE DISCORDANT RESULT(S) WERE OBTAINED ON BOTH THE IMMULITE 2000 INSTRUMENTS, AND THAT THE SAMPLE WAS FROZEN IN BETWEEN TESTING ON THE INSTRUMENT(S). THERE ARE NO REPORTS OF PATIENT
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 8074739 ↗MalfunctionNov 5, 2018Low Test Results; Low Test Results
A DISCORDANT FALSELY LOW RESULT (BELOW REFERENCE RANGE OF THE ASSAY) WAS OBTAINED ON A PATIENT SAMPLE FOR INTACT PARATHYROID (IPTH) ASSAY ON AN IMMULITE 2000 (INSTRUMENT 1) INSTRUMENT WHEN USING IPTH KIT LOT 331. THE SAMPLE WAS REPEATED THE NEXT DAY ON ANOTHER IMMULITE 2000 INSTRUMENT (INSTRUMENT 2) IN THE SAME LABORATORY USING THE SAME IPTH KIT LOT 331 AND THE RESULT WAS STILL LOW. THE SAMPLE WAS THEN REPEATED ON INSTRUMENT 1 AND 2 WITH IPTH KIT LOT 332 AND THE RESULTS WERE STILL LOW. THE SAMPLE WAS THEN REPEATED MULTIPLE TIMES THE NEXT DAY ON INSTRUMENT 2 WITH KIT LOT 332 AND THE RESULT WAS LOW AGAIN. BASED ON THE INFORMATION PROVIDED BY THE CUSTOMER SOME REPLICATES OF QUALITY CONTROL SAMPLES LEVELS 1 AND 2 WERE OUTSIDE OF ACCEPTABLE SPECIFICATIONS ON THE DAY THE DISCORDANT SAMPLES WERE OBTAINED. THE CUSTOMER HAS INDICATED THAT THEY RUN MULTIPLE ASSAY ON THE TWO IMMULITE INSTRUMENTS BUT HAVE NOT REPORTED ANY DISCORDANT PATIENT RESULTS. THERE WERE NO ERROR MESSAGES ON THE SYSTEM WHEN THE DISCORDANT RESULTS WERE OBTAINED. THE CUSTOMER DID NOT PROVIDE INFORMATION ON SAMPLE HANDLING AS THE SAMPLE WAS RUN MULTIPLE TIMES ON THE TWO SYSTEMS WITH DIFFERENT IPTH KIT LOTS. THE INITIAL LOW
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 8038878 ↗MalfunctionNov 5, 2018Low Test Results; Low Test Results
A DISCORDANT FALSELY LOW RESULT (BELOW REFERENCE RANGE OF THE ASSAY ) WAS OBTAINED ON A PATIENT SAMPLE FOR INTACT PARATHYROID (IPTH) ASSAY ON AN IMMULITE 2000 (INSTRUMENT 1) INSTRUMENT WHEN USING IPTH KIT LOT 331. THE SAMPLE WAS REPEATED THE NEXT DAY ON ANOTHER IMMULITE 2000 INSTRUMENT (INSTRUMENT 2) IN THE SAME LABORATORY USING THE SAME IPTH KIT LOT 331 AND THE RESULT WAS STILL LOW. THE SAMPLE WAS THEN REPEATED ON INSTRUMENT 1 AND 2 WITH IPTH KIT LOT 332 AND THE RESULTS WERE STILL LOW. THE SAMPLE WAS THEN REPEATED MULTIPLE TIMES THE NEXT DAY ON INSTRUMENT 2 WITH KIT LOT 332 AND THE RESULT WAS LOW AGAIN. BASED ON THE INFORMATION PROVIDED BY THE CUSTOMER SOME REPLICATES OF QUALITY CONTROL SAMPLES LEVELS 1 AND 2 WERE OUTSIDE OF ACCEPTABLE SPECIFICATIONS ON THE DAY THE DISCORDANT SAMPLES WERE OBTAINED. THE CUSTOMER HAS INDICATED THAT THEY RUN MULTIPLE ASSAY ON THE TWO IMMULITE INSTRUMENTS BUT HAVE NOT REPORTED ANY DISCORDANT PATIENT RESULTS. THERE WERE NO ERROR MESSAGES ON THE SYSTEM WHEN THE DISCORDANT RESULTS WERE OBTAINED. THE CUSTOMER DID NOT PROVIDE INFORMATION ON SAMPLE HANDLING AS THE SAMPLE WAS RUN MULTIPLE TIMES ON THE TWO SYSTEMS WITH DIFFERENT IPTH KIT LOTS. THE INITIAL LOW
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 8038855 ↗MalfunctionNov 5, 2018Low Test Results; Low Test Results
A DISCORDANT FALSELY LOW RESULT (BELOW REFERENCE RANGE OF THE ASSAY ) WAS OBTAINED ON A PATIENT SAMPLE FOR INTACT PARATHYROID (IPTH) ASSAY ON AN IMMULITE 2000 (INSTRUMENT 1) INSTRUMENT WHEN USING IPTH KIT LOT 331. THE SAMPLE WAS REPEATED THE NEXT DAY ON ANOTHER IMMULITE 2000 INSTRUMENT (INSTRUMENT 2) IN THE SAME LABORATORY USING THE SAME IPTH KIT LOT 331 AND THE RESULT WAS STILL LOW. THE SAMPLE WAS THEN REPEATED ON INSTRUMENT 1 AND 2 WITH IPTH KIT LOT 332 AND THE RESULTS WERE STILL LOW. THE SAMPLE WAS THEN REPEATED MULTIPLE TIMES THE NEXT DAY ON INSTRUMENT 2 WITH KIT LOT 332 AND THE RESULT WAS LOW AGAIN. BASED ON THE INFORMATION PROVIDED BY THE CUSTOMER SOME REPLICATES OF QUALITY CONTROL SAMPLES LEVELS 1 AND 2 WERE OUTSIDE OF ACCEPTABLE SPECIFICATIONS ON THE DAY THE DISCORDANT SAMPLES WERE OBTAINED. THE CUSTOMER HAS INDICATED THAT THEY RUN MULTIPLE ASSAY ON THE TWO IMMULITE INSTRUMENTS BUT HAVE NOT REPORTED ANY DISCORDANT PATIENT RESULTS. THERE WERE NO ERROR MESSAGES ON THE SYSTEM WHEN THE DISCORDANT RESULTS WERE OBTAINED. THE CUSTOMER DID NOT PROVIDE INFORMATION ON SAMPLE HANDLING AS THE SAMPLE WAS RUN MULTIPLE TIMES ON THE TWO SYSTEMS WITH DIFFERENT IPTH KIT LOTS. THE INITIAL LOW
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 8038849 ↗MalfunctionNov 5, 2018Low Test Results; Low Test Results
A DISCORDANT FALSELY LOW RESULT (BELOW REFERENCE RANGE OF THE ASSAY ) WAS OBTAINED ON A PATIENT SAMPLE FOR INTACT PARATHYROID (IPTH) ASSAY ON AN IMMULITE 2000 (INSTRUMENT 1) INSTRUMENT WHEN USING IPTH KIT LOT 331. THE SAMPLE WAS REPEATED THE NEXT DAY ON ANOTHER IMMULITE 2000 INSTRUMENT (INSTRUMENT 2) IN THE SAME LABORATORY USING THE SAME IPTH KIT LOT 331 AND THE RESULT WAS STILL LOW. THE SAMPLE WAS THEN REPEATED ON INSTRUMENT 1 AND 2 WITH IPTH KIT LOT 332 AND THE RESULTS WERE STILL LOW. THE SAMPLE WAS THEN REPEATED MULTIPLE TIMES THE NEXT DAY ON INSTRUMENT 2 WITH KIT LOT 332 AND THE RESULT WAS LOW AGAIN. BASED ON THE INFORMATION PROVIDED BY THE CUSTOMER, SOME REPLICATES OF QUALITY CONTROL SAMPLES LEVELS 1 AND 2 WERE OUTSIDE OF ACCEPTABLE SPECIFICATIONS ON THE DAY THE DISCORDANT SAMPLES WERE OBTAINED. THE CUSTOMER HAS INDICATED THAT THEY RUN MULTIPLE ASSAY ON THE TWO IMMULITE INSTRUMENTS BUT HAVE NOT REPORTED ANY DISCORDANT PATIENT RESULTS. THERE WERE NO ERROR MESSAGES ON THE SYSTEM WHEN THE DISCORDANT RESULTS WERE OBTAINED. THE CUSTOMER DID NOT PROVIDE INFORMATION ON SAMPLE HANDLING AS THE SAMPLE WAS RUN MULTIPLE TIMES ON THE TWO SYSTEMS WITH DIFFERENT IPTH KIT LOTS. THE INITIAL LO
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 8038840 ↗MalfunctionOct 8, 2018Low Test Results; Low Test Results
DISCORDANT, FALSELY DEPRESSED RESULTS WERE OBTAINED ON PATIENT SAMPLES FOR THE INTACT PARATHYROID (IPTH) ASSAY ON KIT LOT 333 COMPARED TO KIT LOT 329 ON AN IMMULITE 2000 XPI INSTRUMENT. THE RESULTS OBTAINED ON KIT LOT 333 WERE LOWER THAN THE RESULTS OBTAINED ON KIT LOT 329 FOR THE SAME SAMPLES. THE FALSELY DEPRESSED RESULTS ON KIT LOT 333 WERE REPORTED TO THE PHYSICIAN(S).THE CUSTOMER RAN SAMPLES ON SEPTEMBER 4 AND 6, BUT DID NOT INDICATE TO SIEMENS WHICH SAMPLES WERE RUN ON WHICH DAY. THERE ARE NO REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT, FALSELY DEPRESSED IPTH RESULTS.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 7944002 ↗MalfunctionOct 8, 2018Low Test Results; Low Test Results
DISCORDANT, FALSELY DEPRESSED RESULTS WERE OBTAINED ON PATIENT SAMPLES FOR THE INTACT PARATHYROID (IPTH) ASSAY ON KIT LOT 333 COMPARED TO KIT LOT 329 ON AN IMMULITE 2000 XPI INSTRUMENT. THE RESULTS OBTAINED ON KIT LOT 333 WERE LOWER THAN THE RESULTS OBTAINED ON KIT LOT 329 FOR THE SAME SAMPLES. THE FALSELY DEPRESSED RESULTS ON KIT LOT 333 WERE REPORTED TO THE PHYSICIAN(S).THE CUSTOMER RAN SAMPLES ON (B)(6), BUT DID NOT INDICATE TO SIEMENS WHICH SAMPLES WERE RUN ON WHICH DAY. THERE ARE NO REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT, FALSELY DEPRESSED IPTH RESULTS.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 7943994 ↗MalfunctionSep 17, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
DISCORDANT, FALSELY DEPRESSED RESULTS WERE OBTAINED FOR PATIENT SAMPLES WITH THE IMMULITE 2000 INTACT PTH (PARATHYRIN) ASSAY. THE INITIAL DISCORDANT RESULTS WERE NOT REPORTED TO THE PHYSICIAN(S). THE SAMPLES WERE REPEATED WITH A DIFFERENT REAGENT LOT OF THE SAME ASSAY AND RESULTED HIGHER. THE REPEAT RESULTS WERE IN ALIGNMENT WITH THE CLINICAL PROFILE OF THE PATIENTS. IT IS UNKNOWN IF THE REPEAT RESULTS WERE REPORTED TO THE PHYSICIAN(S). THERE ARE NO KNOWN REPORTS OF ANY IMPACT TO PATIENT TREATMENT OR INTERVENTION DUE TO THE DISCORDANT, FALSELY DEPRESSED INTACT PTH RESULTS. THERE ARE NO KNOWN REPORTS OF A DELAY IN ADMINISTERING TREATMENT OR MEDICAL INTERVENTION TO THE PATIENTS DUE TO THE DISCORDANT, FALSELY DEPRESSED INTACT PTH RESULTS.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 7880511 ↗MalfunctionSep 7, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
DISCORDANT RESULTS WERE OBTAINED FOR PATIENT SAMPLES WITH THE IMMULITE 2000 XPI INTACT PTH (PARATHYRIN) ASSAY. THE SAMPLES WERE REPEATED ON AN ALTERNATE PLATFORM OR ON THE SAME ASSAY AND RESULTED HIGHER. IT IS NOT KNOWN IF ANY OF THE RESULTS WERE REPORTED TO PHYSICIAN(S). THERE ARE NO KNOWN REPORTS OF ANY IMPACT TO PATIENT TREATMENT OR INTERVENTION DUE TO THE DISCORDANT INTACT PTH RESULTS.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 7855370 ↗MalfunctionApr 19, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A DISCORDANT, FALSELY HIGH RESULT WAS OBTAINED FOR INTACT PARATHYROID (IPTH) ON ONE PATIENT SAMPLE ON AN IMMULITE 2000 INSTRUMENT, WHEN USING REAGENT LOT 326 ON (B)(6) 2018. THE CUSTOMER WAS EXPECTING THE RESULT TO BE IN THE NORMAL RANGE. THE SAMPLE WAS THEN DILUTED AND RUN ON THE SAME IMMULITE 2000 INSTRUMENT ON (B)(6) 2018 AND THE VALUES OBTAINED WERE LOWER. THE DISCORDANT RESULT WAS NOT REPORTED TO THE PHYSICIAN(S). IT IS UNKNOWN IF THE RESULTS ON THE DILUTED SAMPLE WERE REPORTED TO THE PHYSICIAN(S). THE SAMPLE WAS RUN NEAT AND DILUTED ON AN ALTERNATE PLATFORM AND THE RESULTS ON BOTH SAMPLES WERE LOWER THAN WHAT WAS OBTAINED ON THE DILUTED SAMPLE ON THE IMMULITE PLATFORM. THERE ARE NO REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCE DUE TO THE DISCORDANT, FALSELY HIGH IPTH RESULT.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 7444693 ↗MalfunctionApr 19, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A DISCORDANT, FALSELY HIGH RESULT WAS OBTAINED FOR INTACT PARATHYROID (IPTH) ON ONE PATIENT SAMPLE ON AN IMMULITE 2000 INSTRUMENT, WHEN USING REAGENT LOT 326 ON (B)(6) 2018. THE SAMPLE WAS TREATED WITH HETEROPHILE ANTIBODY BLOCKING TUBE (HBT) ON (B)(6) 2018 AND RUN NEAT, BUT RECOVERED FALSELY HIGH AGAIN. THE CUSTOMER WAS EXPECTING THE RESULT TO BE IN THE NORMAL RANGE. THE SAMPLE WAS THEN DILUTED AND RUN ON THE SAME IMMULITE 2000 INSTRUMENT AND THE VALUES OBTAINED WERE ACCEPTABLE TO THE CUSTOMER BASED ON PRIOR IPTH RESULTS OBTAINED FOR THIS SAMPLE. THE DISCORDANT RESULTS WERE NOT REPORTED TO THE PHYSICIAN(S). IT IS UNKNOWN IF THE RESULTS ON THE DILUTED SAMPLE WERE REPORTED TO THE PHYSICIAN(S). THERE ARE NO REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCE DUE TO THE DISCORDANT, FALSELY HIGH IPTH RESULT.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 7444692 ↗MalfunctionApr 19, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A DISCORDANT, FALSELY HIGH RESULT WAS OBTAINED FOR INTACT PARATHYROID (IPTH) ON ONE PATIENT SAMPLE ON AN IMMULITE 2000 INSTRUMENT, WHEN USING REAGENT LOT 326 ON (B)(6) 2018. THE SAMPLE WAS TREATED WITH HETEROPHILE ANTIBODY BLOCKING TUBE (HBT) ON (B)(6) 2018 AND RUN NEAT, BUT RECOVERED FALSELY HIGH AGAIN. THE CUSTOMER WAS EXPECTING THE RESULT TO BE IN THE NORMAL RANGE. THE SAMPLE WAS THEN DILUTED AND RUN ON THE SAME IMMULITE 2000 INSTRUMENT AND THE VALUES OBTAINED WERE ACCEPTABLE TO THE CUSTOMER BASED ON PRIOR IPTH RESULTS OBTAINED FOR THIS SAMPLE. THE DISCORDANT RESULTS WERE NOT REPORTED TO THE PHYSICIAN(S). IT IS UNKNOWN IF THE RESULTS ON THE DILUTED SAMPLE WERE REPORTED TO THE PHYSICIAN(S). THERE ARE NO REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCE DUE TO THE DISCORDANT, FALSE ELEVATED IPTH RESULT.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 7444691 ↗MalfunctionApr 19, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A DISCORDANT, FALSELY HIGH RESULT WAS OBTAINED FOR INTACT PARATHYROID (IPTH) ON ONE PATIENT SAMPLE ON AN IMMULITE 2000 INSTRUMENT, WHEN USING REAGENT LOT 326 ON (B)(6) 2018. THE CUSTOMER WAS EXPECTING THE RESULT TO BE IN THE NORMAL RANGE. THE SAMPLE WAS THEN DILUTED AND RUN ON THE SAME IMMULITE 2000 INSTRUMENT ON (B)(6) 2018 AND THE VALUES OBTAINED WERE LOWER. THE DISCORDANT RESULT WAS NOT REPORTED TO THE PHYSICIAN(S). IT IS UNKNOWN IF THE RESULTS ON THE DILUTED SAMPLE WERE REPORTED TO THE PHYSICIAN(S). THE SAMPLE WAS RUN NEAT AND DILUTED ON AN ALTERNATE PLATFORM AND THE RESULTS ON BOTH SAMPLES WERE LOWER THAN WHAT WAS OBTAINED ON THE DILUTED SAMPLE ON THE IMMULITE PLATFORM. THERE ARE NO REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCE DUE TO THE DISCORDANT, FALSELY HIGH IPTH RESULT.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 7444689 ↗
Other Siemens Healthcare Diagnostics Products Ltd products
- IMMULITE 2000 Systems HCG2 models · 189 reports · 1 recall
- IMMULITE 2000 Systems ATG Anti-TG Ab (Anti-Thyroglobulin Ab)2 models · 17 reports · 2 recalls
- IMMULITE 2000 Systems E2 Estradiol2 models · 40 reports · 1 recall
- IMMULITE 2000 Systems PRG Progesterone2 models · 7 reports · 1 recall
- IMMULITE 2000 Systems PTS PSA2 models · 1 reports · 1 recall
Sources and updates
- Models: FDA GUDID, file dated Oct 13, 2026. Models are grouped by the brand name the manufacturer registered.
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page